title: Clinical pharmacokinetics of cefamandole and ceftazidime administered by continuous intravenous infusion.
abstract: In view of the results of animal studies as well as theoretical considerations, continuous administration of beta-lactam antibiotics should be superior to intermittent administration because of the close relationship between efficacy and the duration of time in which the concentration of unbound antibiotics in plasma remains above the MIC. The aim of the present study was to establish the pharmacokinetic parameters of cefamandole and ceftazidime for patients receiving these cephalosporins by continuous infusion. The interindividual differences in the concentrations in plasma at the steady state were mainly attributable to variations in renal function, as estimated by the rate of creatinine clearance. Using these results, we derived formulas for both cephalosporins that can be used to determine on an individual basis the total daily dose needed to obtain a therapeutic concentration in plasma. These formulas were tested with a group of subsequent patients and proved to be practical and fairly reliable. For some patients, a correction for a possible underestimation of the renal clearance at presentation might be required.
authors.affiliation: Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
authors.forename: J
authors.initials: J
authors.lastname: Berkhout
authors.forename: L G
authors.initials: LG
authors.lastname: Visser
authors.forename: P J
authors.initials: PJ
authors.lastname: van den Broek
authors.forename: J A M
authors.initials: JA
authors.lastname: van de Klundert
authors.forename: H
authors.initials: H
authors.lastname: Mattie
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D002435:Cefamandole / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D002442:Ceftazidime / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D003404:Creatinine / Q000097:blood; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged
chemical_list: D000900:Anti-Bacterial Agents; D002435:Cefamandole; D002442:Ceftazidime; D003404:Creatinine